Page last updated: 2024-12-10

pelargonidin-3-glucoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pelargonidin-3-glucoside: structure given in first source; RN given for chloride salt; RN for parent cpd not available 1/93 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pelargonidin 3-O-beta-D-glucoside chloride : A member of the class of anthocyanin chlorides that has pelargonidin 3-O-beta-D-glucoside as the cationic counterpart. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3080714
CHEBI ID36122
SCHEMBL ID316939
MeSH IDM0210368

Synonyms (38)

Synonym
1-benzopyrylium, 3-(beta-d-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, chloride
8h1wzy9r6p ,
unii-8h1wzy9r6p
pelargonidin-3-glucoside
pelargonidin-3-glucopyranoside
CHEBI:36122
3-(beta-d-glucopyranosyloxy)-4',5,7-trihydroxyflavylium chloride
pelargonidin 3-o-beta-d-glucoside chloride
18466-51-8
pelargonidin 3-glucoside
callistephin chloride, >=97.0% (hplc)
pelargonidin 3-o-.beta.-d-glucopyranoside
pelargonidin 3-monoglucoside
pelargonidin 3-.beta.-d-glucopyranoside
pelargonidin 3-glucoside [mi]
3-(.beta.-d-glucopyranosyloxy)-4',5,7-trihydroxyflavylium chloride
3,4',5,7-tetrahydroxyflavylium chloride 3-.beta.-d-glucopyranoside
1-benzopyrylium, 3-(.beta.-d-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-, chloride
pelargonidin 3-.beta.-glucoside
3,4',5,7-tetrahydroxyflavylium chloride 3-glucoside
pelargonidin monoglucoside
SCHEMBL316939
pelargonidin-3-glucoside chloride
mfcd00017578
pelargonidin-3-o-glucoside chloride
callistephin chloride, >=95.0% (hplc)
CAHGSEFWVUVGGL-UBNZBFALSA-N
AKOS030573523
pelargonidin 3-glucoside chloride
(2s,3r,4s,5s,6r)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)chromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;chloride
callistephin (chloride), hplc grade
DTXSID00939866
Q27116710
5,7-dihydroxy-2-(4-hydroxyphenyl)-3-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)chromenylium chloride
callistephin (chloride)
HY-W040045
CS-W020785
AS-78470

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Therefore, this study was aimed at evaluating the effect of interactions among milk protein (beta-lactoglobulin; BLG), polysaccharides (pectin, P; chitosan, CH), and anthocyanin (pelargonidin-3-O-glucoside; P3G) in improving the bioavailability and biological activity of P3G."( In vitro study of bioaccessibility, antioxidant, and α-glucosidase inhibitory effect of pelargonidin-3-O-glucoside after interacting with beta-lactoglobulin and chitosan/pectin.
Chen, W; Gowd, V; Karim, N; Shishir, MRI; Xie, L; Xu, Y, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
anthocyanin chloridesAn organic chloride salt of any anthocyanin.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (55)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (1.82)18.2507
2000's9 (16.36)29.6817
2010's34 (61.82)24.3611
2020's11 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.65 (24.57)
Research Supply Index4.06 (2.92)
Research Growth Index5.39 (4.65)
Search Engine Demand Index37.47 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (3.64%)5.53%
Reviews1 (1.82%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other52 (94.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]